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Abstract: Vitamin C is an important regulatory for iron uptake and vitamin B12 is 
essential for proper functioning of folic acid. Human serum albumin is an abundant 
plasma protein, the major soluble protein constituent of the circulatory system and 
has many physiological functions including transport of a variety of compounds. In 
this work, the molecular interaction between vitamin C and B12with human serum 
albumin was investigated using constant protein concentration and various drug 
concentrations at pH 7.4. Three different spectroscopic methods were used; 
fluorescence spectroscopy, UV absorption and FT-IR spectroscopy. From spectral 
analysis, both vitamins showed a strong ability to quench the intrinsic fluorescence of 
human serum albumin through a static quenching procedure.The binding constant (k) 
is estimated from UV-absorption as k=1.28×104 M-1 for HSA-Vitamin C and 
k=2.21×104 M-1 for HSA-vitamin B12. Both results showed a good agreement with the 
binding constants obtained from the modified Stern-Volmer equation using 
florescence technique. The appearance or disappearance of the bands is a good sign to 
understand the mechanisms at the molecular level. The FT-IR spectral changes 
indicates an increase of intensity for HSA-vitamin C interaction and a reduction of 
intensity for HSA-vitamin B12 interaction. For HSA-vitamin C complexes, positive 
features are related to increase in intensity of the amide I and II bands upon drug-
complexation due to drug binding to protein C=O, C-N and N-H groups. While in the 
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difference spectra of vitamin B12-HSA complexes, intensity decreases as the 
concentration of vitamin B12 increases for amide I band at 1656cm-1, and amid II band 
at 1544 cm-1, this results in stabilization by hydrogen bonding by having the C-N 
bond assuming partial double character due to a flow of electrons from the C=O to 
the C-N. 
Keywords: Vitamin C, Vitamin B12, Human serum albumin, UV-spectroscopy, 
Fluorescence spectroscopy, FT-IR. 
 
1. INTRODUCTION 
Vitamins are organic molecules required in very small quantities in the diet for health, growth, and 
survival1-4. Most vitamins are used for the synthesis of coenzymes, complex organic molecules that 
assist enzymes in catalyzing biochemical reactions, so the absence of a vitamin from the diet or an 
inadequate intake results in characteristic deficiency signs and symptoms reflect an inability of cells 
to carry out certain reactions2, 3. 
Ascorbic acid (vitamin C) is a water-soluble micronutrient required for multiple biological functions 
(Fig. 1),cannot be synthesized by humans and incorporated into our diet5. Vitamin C is an important 
regulator of iron uptake1, 5; reduces ferric to ferrous ions, thus promoting dietary non-iron absorption 
from the gastrointestinal tract, and stabilizes iron-binding proteins6.The two main components of 
vitamin C are ascorbate and dehydroascorbic acid7 .The transport of ascorbate through the human 
body involves two sodium-dependent vitamin C transporters8-10 which work as powerful antioxidant 
capacity11. In a general sense, vitamin C acts as a cofactor and reduces certain enzymes by providing 
them with electrons, due to its chemical structure12. Those enzymes can react with biomolecules 
known as lipids, proteins and DNA, and cause harm10, 13, 14. In order to help prevent that, vitamin C 
reduces oxygen species when lipid peroxidation is formed, reduces radical inhibitors in protein 
oxidation, and prevents nitrosamine formation to reduce DNA damage15. 
 
 
Fig. 1: Chemical structure of Vitamin C (ascorbic acid) 
Vitamin B12, also called cyanocobalamin (Fig. 2), is one of 8 B vitamins16. All B vitamins help the 
body convert food (carbohydrates) into fuel (glucose), which is used to produce energy17. These B 
vitamins help the body use fats and protein18. B complex vitamins are needed for healthy skin, hair, 
eyes, and liver. They also help the nervous system function properly19 .Vitamin B12 is the only vitamin 
containing metal ion (trivalent cobalt) 20. It is needed in many body processes; in the manufacturing 
and the maintenance of red blood cells, the synthesis of DNA, the simulate of nerve cells, the growth 
promotion and energy releases, and the proper functioning of folic acid21-24. Characteristic signs of B12 
deficiency include fatigue, weakness, constipation, loss of appetite, and weight loss25. 
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Fig. 2: Chemical structure of vitamin B12 
Serum albumins are the most crucial protein constituents of the human blood circulation system, 
which fulfill a variety of physiological functions fundamental to human metabolism26-28. One of the 
substantial features of this class of proteins is their ability to perform effective delivery role in case of 
drugs and other biologically active substances29]. Human serum albumin (HSA) is the most abundant 
protein in blood plasma and is able to bind and thereby transport various compounds such as fatty 
acids, hormones, steroids, metal ions, therapeutic ions and a large number of drugs. Strong binding of 
albumin can decrease the concentrations of free drugs in plasma, whereas weak binding can lead to a 
short lifetime or poor distribution30. The interaction between HSA and drugs has been investigated 
using techniques such as electrochemistry31, chromatography32, nuclear magnetic resonance33 and 
spectral analysis. Spectral analysis is widely applied because of its easy operation, low cost, and 
abundant theoretical formulation34. 
The principal objective of this work was to investigate the interaction of HSA complexes with vitamin 
C and vitamin B12 by using Fourier transform infrared spectroscopy (FTIR), thus, the work will be 
limited to the mid-range infrared which covers the frequency range from 4000 to 400 cm-1. Other 
spectroscopic techniques have been used in studying the interaction of drugs with proteins, 
fluorescence and UV spectroscopy are commonly used because of their sensitivity, rapidity and ease 
of implementation. 
2. MATERIALS AND METHODS 
Human serum albumin (fatty acid free) was purchased from Sigma chemical company. Vitamin C and 
vitamin B12 in powder form were also purchased from Sigma chemical company and used without 
further purification. 
2.1. Preparation of stock solutions: HSA was dissolved in 25% ethanol in phosphate buffer Saline 
and at physiological pH of 7.4), to a concentration of (80mg/ml), and used at final concentration of 
(40 mg/ml) in the final vitamin- HSA solution. Vitamin C (molecular weight of 176.13 g.mol-1) and 
vitamin B12 (molecular weight of 1355.4 g.mol-1), were dissolved in 25% ethanol in phosphate buffer 
Saline and, then the solution was placed in ultrasonic water path (SIBATA AU-3T) for one hour  to 
ensure that all the amount of vitamins were completely dissolved. The final concentrations of HSA- 
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Vitamins complexes were prepared by mixing equal volume of HSA to equal volume from different 
concentration of vitamins C and B12. HSA concentration in all samples kept at 40 mg.ml-1. However, 
the final concentrations of the vitamins in solutions are (40 mg.ml-1, 20 mg.ml-1, 10 mg.ml-1, 5 mg.ml-
1, 2 mg.ml-1and 1 mg.ml-1).The solution of vitamins and HSA were incubated for 1 h (at 250C) before 
spectroscopic measurements were taken. 
2.2. UV-VIS spectrophotometer: The absorption spectra were obtained by the use of a Nano Drop 
ND-1000 spectrophotometer. It is used to measure the absorption spectrum of the samples in the 
range between 220-750 nm, with high accuracy and reproducibility. The absorption spectra were 
recorded for free HSA 40 mg.ml-1 and for its complexes with vitamin C and B12solutions with the 
concentrations of (40 mg.ml-1, 20 mg.ml-1, 10 mg.ml-1, 5 mg.ml-1, 2 mg.ml-1and 1 mg.ml-1). Repeated 
measurements were done for all samples. 
2.3. Fluorescence spectrometer: The fluorescence measurements were performed by a Nano Drop 
ND-3300 Fluoro-spectrophotometer at 25°C. The excitation source comes from one of three solid-
state light emitting diodes (LEDs). The excitation source options include: UV LED with maximum 
excitation 365 nm, Blue LED with excitation 470 nm, and white LED from 500 to 650nm excitation. 
A 2048-element CCD array detector covering 400-750 nm, is connected by an optical fiber to the 
optical measurement surface. The excitation is done at the wavelength of 360 nm and the maximum 
emission wavelength is at 439 nm. The emission spectra were recorded for free HSA 40 mg.ml-1 and 
its complexes with vitamins C and B12 solutions with the concentrations of (40 mg.ml-1, 20 mg.ml-1, 
10 mg.ml-1, 5 mg.ml-1, 2 mg.ml-1and 1 mg.ml-1). 
2.4. FT-IR spectroscopy: The FT-IR measurements were obtained on a Bruker IFS 
66/Spectrophotometer equipped with a liquid nitrogen-cooled MCT detector and a KBr beam splitter. 
The spectrometer was continuously purged with dry air during the measurements. The absorption 
spectra were obtained in the wave number range of 400- 4000 cm-1. A spectrum was taken as an 
average of 60 scans to increase the signal to noise ratio, and the spectral resolution was at 4 cm-1. The 
aperture used in this study was 8 mm, since we found that this aperture gives best signal to noise ratio. 
Baseline correction, normalization and peak areas calculations were performed for all the spectra by 
OPUS software. The peak positions were determined using the second derivative of the spectra. The 
infrared spectra of HSA, and vitamins-HSA complexes were obtained in the region of 1000-1800 cm-
1. The FT-IR spectrum of free HSA was acquired by subtracting the absorption spectrum of the buffer 
solution from the spectrum of the protein solution. For the net interaction effect, the difference spectra 
[(protein and vitamins solutions) - (protein solution)] were generated using the featureless region of 
the protein solution 1800-2200 cm-1as an internal standard35. The accuracy of this subtraction method 
is tested using several control samples with the same protein or vitamins concentrations, which 
resulted into a flat base line formation. The obtained spectral differences were used here, to 
investigate the nature of the vitamins-HSA interaction.  
3. RESULTS AND DISCUSSION 
3.1. UV-absorption spectroscopy: UV-absorption spectroscopy was used to determine the binding 
constants between HSA and a drug (Vitamin C and Vitamin B12). The strength of interaction between 
HSA and drugs is dependent on the binding constant which can be calculated using graphical analysis 
of the absorbance spectrum. The excitation has been done on 210 nm and the absorption is recorded at 
268 nm for vitamin C and at 278 nm for vitamin B12.The absorption spectra of different 
concentrations of vitamin C (Fig.3.a) and vitamin B12(Fig.3.b) with HSA showed an increase of the 
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intensity as the vitamin C concentration increases; this is due to major ligand protein interaction at 
protein surface which does not limit the mobility of ligand around HSA molecule while the intensity 
deceases with increasing vitamin B12 concentration which originates from the existence of aromatic 
amino acids being the components of a protein molecule as well as its complicated molecular 
structure. 












                                                                     (1) 
Where A0 corresponds to the initial absorption of protein at 280 nm in the absence of ligand, A∞ is the 
final absorption of the ligated protein, and A is the recorded absorption at different Retinol 
concentrations (L). Fig. 4.a and Fig. 4.b represents the double reciprocal plots of 1/(A- A0) vs. 1/L 
for HSA-vitamin C and HSA-vitamin B12 complexes respectively. The binding constant (K) can be 
estimated from the ratio of the intercept to the slope. The obtained values of the binding constants 
indicates a relatively weak interaction of vitamin C (K= 1.28x104 M-1) and vitamin B12 (K= 2.21x104 
M-1) when compared to other drug-HSA complexes with binding constants in the range13 of 105 and 
106 M-1. The reason for the low stability can be attributed to the presence of mainly hydrogen-bonding 
interaction or an indirect vitamin-HSA interaction through water molecules36. 
 
 
erent concentrations of Vitamin C (a=free HSA, absorbance spectra of HSA with diff-UVFig.3.a:
)1-mg.ml , g=401-mg.ml, f=201-e=10mg.ml, 1-mg.ml, d=51-,c=2mg.ml1-b=1mg.ml 
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(a=free HSA,  12absorbance spectra of HSA with different concentrations of Vitamin B-. UVFig.3.b
)1-, g=40 mg.ml1-, f=20mg.ml1-e=10mg.ml, 1-, d=5mg.ml1-,c=2mg.ml1-b=1mg.ml 
 
Fig.4.a: The plot of 1/(A-Ao) vs. 1/L for HSA with different concentrations of vitamin C. 
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Fig.4.b: The plot of 1/(A-Ao) vs. 1/L for HSA with different concentrations of vitamin B12. 
 
3.2. Fluorescence spectroscopy: It was found that the protein fluorescence quenching can be the 
result of both the interactions, collisional or binding, with other molecules, as well as the inner filter 
effect pertaining to the absorption of light at the excitation or emission wavelength by the compounds 
presented in the solution.  Fluorescence measurements can give some information on the binding 
mechanism of small molecule substances to protein, including binding mode, binding constants, 
binding sites and intermolecular distances. Various molecular interactions can decrease the 
fluorescence intensity of a compound such as molecular rearrangements, exited state reactions, energy 
transfer, ground state complex formation, and collisional quenching37. 
The fluorescence of HSA results from the tryptophan, tyrosine, and phenylalanine residues. The 
intrinsic fluorescence of many proteins is mainly contributed by tryptophan alone, because 
phenylalanine has very low quantum yield and the fluorescence of tyrosine is almost totally quenched 
if it is ionized or near an amino group, a carboxyl group, or a tryptophan residue19, 20, 39, 40.In this work 
for HSA-vitamins complexes excitation wavelength at 360nm was used. The fluorescence sensor is 
based on intramolecular charge transfer (ICT), which is highly sensitive to the polarity of 
microenvironment. Therefore, it is expected to act as fluorescent probe for some biochemical systems 
like proteins41.    
As was observed, the HSA fluorescence spectrum exhibiting the peak maximum at 460 nm (Fig.5.a) 
and the intensity increases as the vitamin C concentration increased while the peak maximum appears 
to be at 440 nm (Fig.5.b) and the fluorescence intensity decreased regularly with increasing of 
vitamin B12 concentration. The peak positions shows little or no change at all. 
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Fig. 5.a: Fluorescence emission spectra of HSA in the absence and presence of vitamin C in these 
concentrations (a=free HSA, b=1mg.ml-1,c=2mg.ml-1, d=5mg.ml-1, e=10mg.ml-1, f=20mg.ml-1, g=40 
mg.ml-1) 
 
Fig. 5.b: Fluorescence emission spectra of HSA in the absence and presence of vitamin B12 in these 
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To elucidate the mechanism of fluorescence quenching, the steady state fluorescence quenching data 
were examined based on the classic Stern-Volmer equation36: 
𝐹0
𝐹
= 1 + 𝐾𝑠𝑣[𝐿] = 1 + 𝑘𝑞𝜏0[𝐿]                                                                                     (2) 
where F0 and F are the HSA fluorescence intensities in the absence and presence of quencher 
(Vitamins C and B12); kq is the HSA bimolecular quenching rate constant; 𝜏0 is the average 
fluorescence lifetime of the HSA molecule without quencher38 (of the order  of 10-8); [L] is the 
concentration of quencher, ksv is Stern-Volmer fluorescence quenching constant. 
As it was already found, the process of fluorescence quenching can proceed via two mechanisms: 
dynamic (collisional, diffusion-limited) and static (diffusion-independent). The Stern-Volmer plots, 
which are linear within certain concentration, may either expose the presence of a single type of 
quenching, or showthe occurrence of just a single binding site for quencher in the 
fluorophoreneighbourhood41-43. The Stern-Volmer plots demonstrate sometimes an upward curvature, 
mainly at higher values of quencher concentration, what could be ascribed to the combined type of 
quenching (both static and dynamic) 44. It appeared that in proteins case the positive deviations from 
the Stern-Volmer equation are also recorded when the extent of quenching is large or the fluorescence 
process is dominated by one single residue (distance-dependent quenching due to a single molecular 
interaction)45. Fig. 6.a and Fig.6.brepresents the Stern-Volmer plot of HSA fluorescence intensities 
of Vitamin C and vitamin B12 respectively.  
 
 
Fig.6.a: The Stern-Volmer plot for vitamin C- HSA complex 
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Fig.6.b:The Stern-Volmer plot for vitamin B12- HSA complex 
 
The curves are linear, suggesting the existence of a single type of quenching (dynamic or static) 
and/or a single binding site for both vitamins in the HSA neighborhood., the values ofthe fluorescence 
quenching constant determined applying Eq. (2) areequal to (9.46 × 103, 2.97 × 104) L mol-1 for 
vitamins C andB12 respectively, both values are much lower than other ksv values for the similar 
systems signalized earlier in literature1,44. The calculated ksv valuesare much too large to be caused by 
collisional quenching in water (two-three orders of magnitude larger), as well as the values of kq, 
which are equal to(9.46 × 1011, 2.97 × 1012) L mol-1 s-1 for vitamins C and B12 . These values confirms 
clearly the existence of static (diffusion- independent) mechanism of fluorescence quenching10, 44.  
Obviously, the values of kq were greater than that of the maximum dynamic quenching constant. This 
suggested that the fluorescence quenching was not the result of dynamic quenching, but the 
consequence of static quenching43, 45. When static quenching is dominant, the modified Stern- Volmer 










                                                                                           (3)       
 
Where K is the binding constant of vitamin-HSA. To determine the binding constants of HSA- 






  for different vitamins ratios are made and shown in Fig. 7.a and 







according to eq. (3). The values of K were found to be (1.3× 104M-1, 2.29 × 104 M-1), 
which agrees well with the values obtained earlier by UV spectroscopy and supports the effective role 
of static quenching.  
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Fig. 7.a: The plot of 1/(F0-F) vs. 1/[L× 105] for HSA-Vitamin C 
 
Fig. 7.b: The plot of 1/(F0-F) vs. 1/[L× 105] for HSA-Vitamin B12 
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3.2. FT-IR spectroscopy: FT-IR spectroscopy is a powerful technique for the study of hydrogen 
bonding46, and has been identified as one of the few techniques that is established in the determination 
of protein secondary structure at different physiological systems8, 37. The information on the secondary 
structure of proteins could be deduced from the infrared spectra. Proteins exhibit a number of amide 
bands, which represent different vibrations of the peptide moiety. The amide group of proteins and 
polypeptides presents characteristic vibrational modes (amide modes) that are sensitive to the protein 
conformation and largely been constrained to group frequency interpretations14, 23. 
The modes most widely used in protein structural studies are amide I, amide II and amide III. Amide I 
band ranging from 1700 to 1600 cm-1 and arises principally from the C=O stretching44,has been 
widely accepted to be used 46. The amide II band is primarily N-H bending with a contribution from 
C-N stretching vibrations; amide I ranging from 1600 to 1480 cm-1 while amide III band ranging from 
1330 to 1220 cm-1 which is due to the C-N stretching mode coupled to the in-plane N - H 
bendingmode47. 
The second derivative of free HSA is shown in Fig. 8.a, where the spectra is dominated by 
absorbance bands of amide I and amide II at peak positions 1656 and 1544cm-1. Figures (8.b&8.c) 




Fig. 8.a: Second derivative of free HSA. 
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Fig. 8.b: Different spectra of HSA and its complexes with different vitamin C concentrations in the 
region 1800-1200 cm-1. 
 
Fig. 8.c: Different spectra of HSA and its complexes with different vitamin B12 concentrations in the 
region 1800-1200 cm-1. 
 
 
 C:\mohammad abu-allan\free HSA.0          20mg-ml-vit.B12-with40mg-ml-HSA          sample
 C:\mohammad abu-allan\1mg-ml-vit.C-with40mg-ml-HSA.0          1mg-ml-vit.C-with40mg-ml-HSA          sample
 C:\mohammad abu-allan\2mg-ml-vit.C-with40mg-ml-HSA.0          2mg-ml-vit.C-with40mg-ml-HSA          sample
 C:\mohammad abu-allan\1mg-ml-vit.C-with40mg-ml-HSA.0          1mg- l-vit.C-with40mg-ml-HSA          sample
 C:\mohammad abu-allan\free HSA.0          20mg-ml-vit.B12-with40mg-ml-HSA          sample
 C:\mohammad abu-allan\1mg-ml-vit.C-with40mg-ml-HSA.0          1mg-ml-vit.C-with40mg-ml-HSA          sample












































































































































































 C:\mohammad abu-allan\free HSA.0          20mg-ml-vit.B12-with40mg-ml-HSA          sample
 C:\mohammad abu-allan\1mg-ml-vit.B12-with40mg-ml-HSA.0          1mg-ml-vit.B12-with40mg-ml-HSA          sample
 C:\mohammad abu-allan\20mg-ml-vit.B12-with40mg-ml-HSA.0          20mg-ml-vit.B12-with40mg-ml-HSA          sample
 C:\mohammad abu-allan\40mg-ml-vit.B12-with40mg-ml-HSA.0          40mg-ml-vit.B12-with40mg-ml-HSA          sample
 C:\mohammad abu-allan\5mg-ml-vit.B12-with40mg-ml-HSA.1          5mg-ml-vit.B12-with40mg-ml-HSA          sample
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The peak positions of HSA with different concentrations of vitamins C and B12 are listed in tables 1& 




Table 1:. Band assignment in the absorbance spectra of HSA with different vitamin C concentrations 


















Table 2: Band assignment in the absorbance spectra of HSA with different vitamin B12 concentrations 




























Amid I  
(1600-1700) 
1658 1658 1658 1655 1654 1651 1650 
1620 1615 1598 1614 1597 1620 1607 
Amid II  
(1480-1600) 
1598 1598 1597 1596 1595 1593 1591 
1547 1546 1546 1546 1545 1544 1544 
1489 1489 1487 1485 1484 1484 1482 
 1479 1478 1477 1477 1476 1473 1473 
 1455 1452 1452 1451 1451 1451 1449 
 1429 1427 1427 1426 1426 1426 1426 
 1400 1399 1399 1398 1398 1398 1397 
 1368 1368 1367 1366 1366 1366 1362 
 1363 1361 1361 1358 1358 1356 1355 
Amid III  
(1220-1330) 
1310 1310 1309 1308 1308 1306 1304 
1248 1247 1247 1246 1246 1245 1244 
























 1704 1705 1705 1706 1710 1710 1712 
Amid I  
(1600-1700) 
1656 1656 1656 1658 1658 1659 1661 
1601 1606 1608 1615 1616 1624 1617 
Amid II  
(1480-1600) 
1569 1569 1571 1573 1576 1578 1580 
1543 1544 1544 1544 1545 1545 1546 
 1478 1478 1481 1481 1484 1485 1490 
 1451 1451 1451 1451 1451 1453 1457 
 1398 1400 1399 1400 1401 1400 1415 
Amid III  
(1220-1330) 
1302 1307 1310 1309 1310 1311 1312 
1246 1247 1248 1247 1247 1250 1256 
 1204 1209 1210 1212 1214 1216 1220 
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An intensity increase in the difference spectra of the vitamin C-HSA complexes was observed for the 
protein amide I band at 1656 cm-1and amide II at 1544 cm-1. Positive features are located in the 
difference spectra for amide I and II bands at 1660 cm-1 and 1548 cm-1(vitamin C). These positive 
features are related to increase in intensity of the amide I and II bands upon drug-complexation due to 
drug binding to protein C=O, C-N and N-H groups. Additional evidence comes from the decrement of 
the peak positions as the concentration of vitamin C increases as shown in table 1. 
In the difference spectra of vitamin B12-HSA complexes, the intensity decreases as the concentration 
of vitamin B12increases for amide I band at 1656cm-1, and amid II band at 1544 cm-1. Table 2. 
Provides an increment of the peak positions as the concentration of vitamin B12 increases; this results 
in stabilization by hydrogen bonding by having the C-N bond assuming partial double character due 
to a flow of electrons from44 the C=O to the C-N. 
SUMMARY AND CONCLUSIONS 
In summary, the binding of vitamin C and vitamin B12 to HSA has been investigated by UV-
absorption spectroscopy, fluorescence spectroscopy and by FT-IR spectroscopy. The binding constant 
values indicate a relatively weak binding of both vitamins with HSA and the quenching constant 
indicate that the intrinsic fluorescence of HSA was quenched by both vitamins through static 
quenching mechanism.  Analysis of FT-IR spectra reveals that HSA-vitamin C interaction induces 
intensity increment while HSA-vitamin B12 interaction induces intensity reduction.  
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